LIPI — Lipidor AB Share News
0.000.00%
Last trade - 00:00- SEK174.88m
- SEK152.13m
- SEK0.01m
Brief: Lipidor Oper Loss Narrows To SEK 8.6 Mln
Brief: Lipidor Q2 Net Income at SEK -5.6 Million
Brief: Lipidor Completes Rights Issue, Resolves On Compensation Issue
Brief: Lipidor Gets SEK 38 Mln In Rights Issue
Brief: Lipidor: Preliminary Outcome In Rights Issue
Brief: Lipidor Q1 EBIT at SEK -647,000
Brief: Lipidor Q4 EBIT at SEK -5.6 Million
Brief: Lipidor Completes SEK 1.7 Mln Sale Of Animal Segment Patent
Brief: Lipidor Adds Sek 1.1 Mln Through Sale Of Shares In Associated Company
Brief: Lipidor Q3 Operating Loss Narrows To SEK 4.0 Mln
Brief: Lipidor Submits New Patent Application
Brief: Lipidor Extends And Expands Cooperation With Relife
Brief: Lipidor Signs Agreement For Clinical Phase III Study
Brief: Lipidor Sees Better Potential For AKP02G2
Brief: Lipidor Raises Short-Term Funding
Brief: Lipidor Says Swedish Medical Products Agency Confirms Clinical Plan For Akp02
Brief: Lipidor Targets New Phase III Study Of AKP02 In 2024
Brief: Lipidor Q1 Operating Loss Narrows To SEK 2.3 Mln
Brief: Lipidor Q4 Oper Loss Narrows To SEK 9 Mln